European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission
Mark Lawler(Queen's University Belfast), Richard Sullivan(Precision Spine (United States)), Jacek Jassem(Gdańsk Medical University), Lynne Davies(World Cancer Research Fund International), Maja Južnič Sotlar, Daniel Kelly(Royal College of Nursing), Kathy Oliver(Brain Tumour Charity), Marius Geantă, Teodora Kolarova, Olaf Kelm(Centre International de Recherche sur le Cancer), Beata Jagielska(The Maria Sklodowska-Curie National Research Institute of Oncology), Kathi Apostolidis(European CanCer Organisation), Yolande Lievens(Ghent University Hospital), Mirjam Crul(Amsterdam University Medical Centers), Fátima Cardoso(Breast Cancer Alliance), Matti Aapro(Clinique de Genolier), Ajay Aggarwal(King's College London), Csaba László Dégi(Babeș-Bolyai University), Isabel T. Rubio(Clinica Universidad de Navarra), Urszula Wojciechowska(The Maria Sklodowska-Curie National Research Institute of Oncology), Sema Erdem(European CanCer Organisation), Jolanda C. van Hoeve(Netherlands Comprehensive Cancer Organisation), Bengt Jönsson(Stockholm School of Economics), Michel P. Coleman(University of London), Grant Lewison(King's College London), Alexander M.M. Eggermont(University Medical Center Utrecht), Andreas Charalambous(University of Turku), Jan Geißler(Stiftung Patientensicherheit Schweiz), Anna Schmutz(Centre International de Recherche sur le Cancer), Tanja Čufer(University of Ljubljana), Peter Naredi(European CanCer Organisation), Jana Pelouchová, Tezer Kutluk(Turkish Society of Hematology), Anne‐Marie Baird(Trinity College Dublin), Willien Westerhuis(Organisation of European Cancer Institutes), Carlo La Vecchia(University of Milan), Simon Oberst(Cancer Research UK), Beate Rau(Medizinische Hochschule Hannover), Peter J. Selby(Centre for Addiction and Mental Health), Gilliosa Spurrier‐Bernard, Richard Price(European CanCer Organisation), Eduard Vrdoljak(University of Split), Thierry Philip(Centre Léon Bérard), Alberto Costa(MultiMedica), Claudia Allemani(London Cancer), Françoise Meunier(Fondation FondaMental), Federica Di Nicolantonio(Candiolo Cancer Institute)
Cited by 104
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
The size and burden of mental disorders and other disorders of the brain in Europe 2010
|European Neuropsychopharmacology|2011|3.8k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2019|2.2k